Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
(Galantamine + metformin) by Rejuvenate Biomed for Sarcopenia: Likelihood of Approval
(Galantamine + metformin) is under clinical development by Rejuvenate Biomed and currently in Phase I for Sarcopenia. According to GlobalData,...
Data Insights
(Galantamine + metformin) by Rejuvenate Biomed for Muscle Atrophy: Likelihood of Approval
(Galantamine + metformin) is under clinical development by Rejuvenate Biomed and currently in Phase I for Muscle Atrophy. According to...